Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward

Majdy Idrees, Ghazwan Butrous, Ana Mocunbi, Bhagavathula Sastry, Ahmed Ibrahim, Khalid Alobaidallah, Ahmed Hassan, Ayman AH Farghaly, Magdi Yacoub

Abstract


Pulmonary hypertension (PH) is a disease that can only be appropriately managed in the ‘rich’ developed countries, as both diagnostic and therapeutic interventions are extremely expensive and expectations for these to be adopted by the developing, economically-challenged countries are neither practical nor realistic. Furthermore, most of the enormous advances in understanding the pathobiology of PH and the subsequent evidence-based diagnostic and complex treatment algorithms came from the developed world.


Full Text:

PDF


DOI: http://dx.doi.org/10.21542/gcsp.2020.14

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Majdy Idrees, Ghazwan Butrous, Ana Mocunbi, Bhagavathula Sastry, Ahmed Ibrahim, Khalid Alobaidallah, Ahmed Hassan, Ayman AH Farghaly, Magdi Yacoub

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.